EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

AMOTL2: A key regulator of mechanotransduction in development, vascular disease and cancer

Pedro Fonseca, Yuanyuan Zhang, Lars Holmgren

Cells & Development · 2026-11 · 204119

DOI: 10.1016/j.cdev.2026.204119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells & Development, 2026-11. Verfasst von Pedro Fonseca und 2 weiteren Autor:innen. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Cancer Society, Swedish Research Council, The Swedish Heart Lung Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Swedish Cancer Society
  • Swedish Research Council
  • The Swedish Heart Lung Foundation

Zitieren

APA

Fonseca, P., Zhang, Y., & Holmgren, L. (2026). AMOTL2: A key regulator of mechanotransduction in development, vascular disease and cancer. Cells & Development, 204119. https://doi.org/10.1016/j.cdev.2026.204119

Vancouver

Fonseca P, Zhang Y, Holmgren L. AMOTL2: A key regulator of mechanotransduction in development, vascular disease and cancer. Cells & Development. 2026:204119. doi:10.1016/j.cdev.2026.204119

BibTeX
@article{Fonseca2026,
  author = {Fonseca, Pedro and Zhang, Yuanyuan and Holmgren, Lars},
  title = {AMOTL2: A key regulator of mechanotransduction in development, vascular disease and cancer},
  journal = {Cells & Development},
  year = {2026},
  pages = {204119},
  doi = {10.1016/j.cdev.2026.204119}
}
Kostenlos starten →